Nippon Life Global Investors Americas, Inc. Charles River Laboratories International, Inc. Transaction History

Nippon Life Global Investors Americas, Inc.

$2.21 Billion
Q2 2025

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2024 May 15, 2024	BUY	$203.52 - $273.43 $3.59 Million - $4.82 Million	17,630 Added 381.6%	22,250 $6.03 Million
Q4 2022 Feb 14, 2023	BUY	$197.11 - $250.07 $910,648 - $1.16 Million	4,620 New	4,620 $1.01 Million

Others Institutions Holding CRL

# of Institutions

615

Shares Held

56.7M

Call Options Held

1.41M

Put Options Held

1.4M

Vanguard Group Inc Valley Forge, PA

5.81M
Shares

$888 Million
0.01% of portfolio
Black Rock Inc. New York, NY

5.09M
Shares

$777 Million
0.02% of portfolio
Nomura Holdings Inc Tokyo, M0

5.07M
Shares

$775 Million
1.32% of portfolio
Wellington Management Group LLP Boston, MA

3.77M
Shares

$576 Million
0.11% of portfolio
Allspring Global Investments Holdings, LLC

2.29M
Shares

$350 Million
0.63% of portfolio

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $7.77B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nippon Life Global Investors Americas, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Nippon Life Global Investors Americas, Inc. with notifications on news.

Account